Literature DB >> 25782337

Utility of the shock index in patients with sepsis.

Jim Tseng1, Kenneth Nugent.   

Abstract

The shock index (SI) equals the heart rate/systolic blood pressure and has been used to predict clinical outcomes, especially in trauma and surgery patients. The authors reviewed the literature to determine its utility in the management of patients with sepsis and in the prediction of adverse outcomes in these patients. The medical literature was searched using PubMed, Scopus, Web of Science and Google Scholar databases to identify articles in English on the SI in humans. These studies demonstrated that the SI could help evaluate the adequacy of fluid resuscitation and the potential response to additional fluid. It can predict the presence of lactic acidosis. The SI also helps predict the development of organ failure and mortality. Consequently, this easily available bedside measurement has utility in the identification, management and prediction of prognosis in patients with sepsis.

Entities:  

Mesh:

Year:  2015        PMID: 25782337     DOI: 10.1097/MAJ.0000000000000444

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

1.  Comparison of four different threshold values of shock index in predicting mortality of COVID-19 patients.

Authors:  Rohat Ak; Fatih Doğanay
Journal:  Disaster Med Public Health Prep       Date:  2021-12-23       Impact factor: 1.385

2.  Association between prehospital shock index variation and 28-day mortality among patients with septic shock.

Authors:  Romain Jouffroy; Basile Gilbert; Léa Thomas; Emmanuel Bloch-Laine; Patrick Ecollan; Josiane Boularan; Vincent Bounes; Benoit Vivien; Papa-Ngalgou Gueye
Journal:  BMC Emerg Med       Date:  2022-05-19

Review 3.  Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Authors:  Axel Nierhaus; Giorgio Berlot; Detlef Kindgen-Milles; Eckhard Müller; Massimo Girardis
Journal:  Ann Intensive Care       Date:  2020-10-07       Impact factor: 6.925

4.  Distribution of shock index and age shock index score among trauma patients in India.

Authors:  Prashant Bhandarkar; Ashok Munivenkatappa; Nobhojit Roy; Vineet Kumar; Veda Dhruthy Samudrala; Amit Agrawal
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Apr-Jun

5.  Delayed recognition of fatal invasive meningococcal disease in adults.

Authors:  Frederick W Nagel; Ifeoma Ezeoke; Mike Antwi; Paula E Del Rosso; Marie Dorsinville; Beth M Isaac; Althea Hayden; Robert S Hoffman; Scott D Weingart; Don Weiss
Journal:  JMM Case Rep       Date:  2016-06-28

6.  Derivation and Validation of Shock Index as a parameter for Predicting Long-term Prognosis in Patients with Acute Coronary Syndrome.

Authors:  Tongtong Yu; Chunyang Tian; Jia Song; Dongxu He; Zhijun Sun; Zhaoqing Sun
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  Comparative study on quick sequential organ failure assessment, systemic inflammatory response syndrome and the shock index in prehospital emergency patients: single-site retrospective study.

Authors:  Masahiro Harada; Takeshi Takahashi; Yoshio Haga; Takeshi Nishikawa
Journal:  Acute Med Surg       Date:  2019-02-05

8.  Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach.

Authors:  Lorenzo Falsetti; Vincenzo Zaccone; Giovanna Viticchi; Agnese Fioranelli; Ilaria Diblasi; Emanuele Guerrieri; Consuelo Ferrini; Mattia Scarponi; Luca Giuliani; Caterina Scalpelli; Marianna Martino; Adolfo Pansoni; Marinella Luccarini; Maurizio Burattini; Gianluca Moroncini; Nicola Tarquinio
Journal:  Diagnostics (Basel)       Date:  2022-02-13

9.  A Multidisciplinary Sepsis Program Enabled by a Two-Stage Clinical Decision Support System: Factors That Influence Patient Outcomes.

Authors:  Robert C Amland; James M Haley; Jason J Lyons
Journal:  Am J Med Qual       Date:  2015-10-21       Impact factor: 1.852

Review 10.  Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.